Safety and Efficacy of PG101 for Dry Eye Syndrome

Inclusion Criteria: * Be male or female of any race, at least 18 years of age * Have provided verbal and written informed consent * Be able and willing to follow instructions, including participation in all study assessments and visits * Have a reported history of dry eye syndrome * Have a history of use or desire to use eye drops for dry eye * If a woman of childbearing potential, have a negative pregnancy test at Visit 1 and be using an adequate method of birth control throughout the study period * Have a best corrected visual acuity of +0.70 logMAR or better in both eyes Exclusion Criteria: * Have any clinically significant eye findings that require therapeutic treatment or may interfere with study parameters * Be diagnosed with an ongoing ocular infection (bacterial, viral, or fungal), or active ocular inflammation (e.g. follicular conjunctivitis) at Visit 1 * Be a woman who is pregnant, nursing or planning a pregnancy * Have a known allergy and/or sensitivity to the test article or its components * Have a condition or be in a situation which the investigator feels may put the subject at significant risk, may confound the study results, or may interfere significantly with the subject's participation in the study * Be currently enrolled in an investigational drug or device study or have used an investigational drug or device within 30 days of Visit 1